Earlier, we demonstrated that the serological assessment of IgG and IgM against SARS-CoV-2 nucleocapsid (NC) and spike (SP) proteins is reliable in differentiating humoral responses to infection versus vaccination [5,7]. This evidence concerns the gene CD40LG and infection.